Clinical Trials Directory

Trials / Sponsors / AnewPharma

AnewPharma

Industry · 14 registered clinical trials.

StatusTrialPhaseStarted
CompletedThe Absorption, Metabolism and Excretion of [14C]CM082 in Human
Advanced Solid Tumor
Phase 12021-07-05
CompletedBioequivalency Study of CM082 Tablet in Healthy Volunteers
Advanced Malignant Solid Tumors
Phase 12020-06-01
CompletedA Study to Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers
Advanced Malignant Solid Tumors
Phase 12019-12-19
SuspendedCM082 in Patients With Myopic Choroidal Neovascularization (CNV)
Myopic Choroidal Neovascularisation
Phase 12019-12-18
UnknownCM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)
Small Cell Lung Cancer
Phase 22019-09-18
UnknownCM082 and JS001 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).
Non-small Cell Lung Cancer
Phase 22019-04-02
UnknownStudy of Challenge Meditech 082 (CM082) Tablets in Patients With Advanced Malignant Solid Tumors
Advanced Malignant Solid Tumors
Phase 12019-02-26
UnknownSafety and Tolerability of Oral CM082 in Patients With wAMD
Age-Related Macular Degeneration
Phase 22018-11-22
UnknownStudy of the Combination of CM082 With JS001 in Patients With Advanced Mucosal Melanoma.
Mucosal Melanoma
Phase 22018-07-31
UnknownSecond-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer
Advanced Gastric Cancer
Phase 12018-03-15
UnknownCM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma
Renal Cell Cancer Metastatic
Phase 32016-12-16
UnknownStudy of the Combination of CM082 With Everolimus in Patients With mRCC
Renal Cell Carcinoma Recurrent
Phase 12015-09-01
SuspendedPhase 1 Study of CM082 in Patients With wAMD
Age-Related Macular Degeneration
Phase 12015-03-01
CompletedPhase 1 Study of CM082 (X-82) Tablets in Advanced Cancer Patients in China
Advanced Cancer
Phase 12013-05-01